Welcome to LookChem.com Sign In|Join Free

CAS

  • or

441715-01-1

2-Bromo-5-fluorobenzothiazole is a chemical compound that belongs to the group of organobromides and organofluorides. It features a benzothiazole core with bromine and fluorine atoms as substituents, which imparts specific reactivity to the molecule. 2-BROMO-5-FLUOROBENZOTHIAZOLE is primarily used in organic synthesis and as a raw material or intermediate in the production of pharmaceuticals and agrochemicals. Due to its potential health risks, it must be handled with caution.

441715-01-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 441715-01-1 Structure

  • Basic information

    1. Product Name: 2-BROMO-5-FLUOROBENZOTHIAZOLE
    2. Synonyms: 2-BROMO-5-FLUOROBENZOTHIAZOLE;2-broMo-5-fluoro-1,3-benzothiazole;2-broMo-5-fluorobenzo[d]thiazole
    3. CAS NO:441715-01-1
    4. Molecular Formula: C7H3BrFNS
    5. Molecular Weight: 232.0728
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 441715-01-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 298.3 °C at 760 mmHg
    3. Flash Point: 134.2 °C
    4. Appearance: /
    5. Density: 1.832 g/cm3
    6. Vapor Pressure: 0.00227mmHg at 25°C
    7. Refractive Index: 1.687
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 2-BROMO-5-FLUOROBENZOTHIAZOLE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-BROMO-5-FLUOROBENZOTHIAZOLE(441715-01-1)
    12. EPA Substance Registry System: 2-BROMO-5-FLUOROBENZOTHIAZOLE(441715-01-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 441715-01-1(Hazardous Substances Data)

441715-01-1 Usage

Uses

Used in Organic Synthesis:
2-Bromo-5-fluorobenzothiazole is used as a building block in organic synthesis for the creation of various complex organic molecules. Its unique structure and reactivity make it a valuable component in the synthesis of specialty chemicals and materials.
Used in Pharmaceutical Industry:
2-Bromo-5-fluorobenzothiazole is used as a raw material or intermediate in the production of pharmaceuticals. Its specific reactivity and structural features contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
2-Bromo-5-fluorobenzothiazole is also utilized in the agrochemical industry as a precursor for the synthesis of various agrochemicals, such as pesticides and herbicides. Its unique properties allow for the development of effective and targeted agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 441715-01-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,1,7,1 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 441715-01:
(8*4)+(7*4)+(6*1)+(5*7)+(4*1)+(3*5)+(2*0)+(1*1)=121
121 % 10 = 1
So 441715-01-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H3BrFNS/c8-7-10-5-3-4(9)1-2-6(5)11-7/h1-3H

441715-01-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-5-fluoro-1,3-benzothiazole

1.2 Other means of identification

Product number -
Other names 2-BROMO-5-FLUOROBENZOTHIAZOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:441715-01-1 SDS

441715-01-1Relevant articles and documents

Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6- benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist

Setoguchi, Masaki,Iimura, Shin,Sugimoto, Yuuichi,Yoneda, Yoshiyuki,Chiba, Jun,Watanabe, Toshiyuki,Muro, Fumihito,Iigo, Yutaka,Takayama, Gensuke,Yokoyama, Mika,Taira, Tomoe,Aonuma, Misato,Takashi, Tohru,Nakayama, Atsushi,MacHinaga, Nobuo

experimental part, p. 1201 - 1212 (2012/03/26)

For the purpose of obtaining orally potent VLA-4 inhibitors, we have carried out structural modification of the (N′-phenylureido)phenyl group in compound 1, where the group was found to be attributed to poor pharmacokinetic profile in our previous research. Through modification, we have identified several compounds with both potent in vitro activity and improved oral exposure. In particular, compound 7e with 7-fluoro-2-(1-methyl-1H-indol-3- yl)-1,3-benzoxazolyl group as a novel replacement of the (N′-phenylureido) phenyl group significantly inhibited eosinophil infiltration into bronchoalveolar lavage fluid at 15 mg/kg in an Ascaris-antigen-induced murine bronchial inflammatory model, and its efficacy was comparable to that of the anti-mouse α4 antibody (R1-2).

VLA-4 INHIBITOR

-

, (2008/06/13)

An object of the present invention is to provide a compound which selectively inhibits binding of a ligand and ±421 integrin (VLA-4), a process for producing the compound, and a medicament containing the compound. A compound represented by the formula (I) etc. orasaltthereof, a process for producing the compound or a salt thereof, a medicament containing the compound or a salt thereof, as well as a preventive and/or a therapeutic agent for a disease caused by cell adhesion, for example, inflammatory reaction, autoimmune disease, cancer metastasis, bronchial asthma, nasal obstruction, diabetes, arthritis, psoriasis, multiple sclerosis, inflammatory bowel disease and rejection reaction at transplantation, containing the compound or a salt thereof as a primary component. [wherein Y 1 represents a divalent aryl group etc. , V 1 represents an aryl group etc., and R 11 to R 14 represent H, OH or a halogen atom etc.]

VLA-4 INHIBITOR

-

Page/Page column 262-263, (2010/02/15)

A compound which selectively inhibits bonding between a ligand and α4β1 integrin (VLA-4); a process for producing the compound; and a medicine containing the compound. The compound is one represented by, e.g., the formula (I) or a salt thereof. Also provided is a preventive and/or therapeutic agent which contains the compound or salt as a major component and is effective against diseases attributable to cell adhesion, such as, e.g., inflammatory reaction, autoimmune disease, cancer metastasis, bronchial asthma, nasal obstruction, diabetes, arthritis, psoriasis, multiple sclerosis, inflammatory intestinal disease, and rejection reaction in transplantation. (In the formula, Y1 represents arylene, etc.; V1 represents aryl, etc.; and R11 to R14 each represents H, OH, halogeno, etc.)

VLA-4 INHIBITORS

-

, (2008/06/13)

The present invention relates to a compound represented by the following formula (I): (wherein, W represents WA-A1 -WB - (in which, WA is substituted or unsubstituted aryl, etc., A1 is -NR1-, single bond, -C(O)-, etc., and WB is substituted or unsubstituted arylene, etc.), R is single bond, -NH-, -OCH2-, alkenylene, etc., X is -C(O) -CH2-, etc., and M is, for example, the following formula: (in which, R11, R12 and R13 each independently represents hydrogen, hydroxyl, amino, halogen, etc., R14 is hydrogen or lower alkyl, Y represents -CH2-O-, etc., Z is substituted or unsubstituted arylene, etc., A2 is single bond, etc, and R10 is hydroxyl or lower alkoxy)), or salt thereof; and a medicament containing the same. This compound or salt thereof selectively inhibits binding of cell adhesion molecules to VAL-4 and exhibits high bioavailability so that it is useful as a preventive and/or remedy for inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, diabetes, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 441715-01-1